Compare KELYA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KELYA | SENS |
|---|---|---|
| Founded | 1946 | 1996 |
| Country | United States | United States |
| Employees | 4900 | N/A |
| Industry | Professional Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.1M | 301.2M |
| IPO Year | N/A | 2014 |
| Metric | KELYA | SENS |
|---|---|---|
| Price | $11.37 | $6.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $15.00 | ★ $18.38 |
| AVG Volume (30 Days) | 429.4K | ★ 495.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $74.15 |
| Revenue Next Year | $4.60 | $58.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $7.98 | $0.41 |
| 52 Week High | $14.94 | $8.75 |
| Indicator | KELYA | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 48.64 |
| Support Level | $8.30 | $6.40 |
| Resistance Level | $12.01 | $6.87 |
| Average True Range (ATR) | 0.43 | 0.49 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 14.31 | 15.67 |
Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.